Sangamo Therapeutics
SGMO
#7008
Rank
โ‚ฌ0.39 B
Marketcap
1,87ย โ‚ฌ
Share price
0.51%
Change (1 day)
452.11%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): -1,34ย โ‚ฌ

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,37ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,19ย โ‚ฌ a decrease over its 2021 EPS that were of -1,18ย โ‚ฌ.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,34ย โ‚ฌ12.61%
2022-1,19ย โ‚ฌ0.81%
2021-1,18ย โ‚ฌ33.33%
2020-0,89ย โ‚ฌ6.9%
2019-0,83ย โ‚ฌ22.54%
2018-0,68ย โ‚ฌ1.43%
2017-0,67ย โ‚ฌ-31.37%
2016-0,97ย โ‚ฌ75.86%
2015-0,55ย โ‚ฌ48.72%
2014-0,37ย โ‚ฌ-17.02%
2013-0,45ย โ‚ฌ9.3%
2012-0,41ย โ‚ฌ-39.44%
2011-0,68ย โ‚ฌ29.09%
2010-0,53ย โ‚ฌ22.22%
2009-0,43ย โ‚ฌ-25%
2008-0,57ย โ‚ฌ3.45%
2007-0,55ย โ‚ฌ5.45%
2006-0,53ย โ‚ฌ10%
2005-0,48ย โ‚ฌ-9.09%
2004-0,53ย โ‚ฌ30.95%
2003-0,40ย โ‚ฌ-65.29%
2002-1,16ย โ‚ฌ15.24%
2001-1,00ย โ‚ฌ3.96%
2000-0,96ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
4,19ย โ‚ฌ-404.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,92ย โ‚ฌ 185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
13,51ย โ‚ฌ-1,082.64%๐Ÿ‡บ๐Ÿ‡ธ USA
17,62ย โ‚ฌ-1,381.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1,76ย โ‚ฌ-227.78%๐Ÿ‡บ๐Ÿ‡ธ USA
13,45ย โ‚ฌ-1,078.15%๐Ÿ‡บ๐Ÿ‡ธ USA
0,74ย โ‚ฌ-154.07%๐Ÿ‡บ๐Ÿ‡ธ USA
1,74ย โ‚ฌ-226.51%๐Ÿ‡บ๐Ÿ‡ธ USA